Action PowerUp Acquisition - PWUP

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

9,24

Prix Achat

9,24

Prix Vente

8,96

Volume échangé

0,00 Fourchette du Jour 0,00

8,05 Plage de 52 semaines 15,80

Cap du marché

83,079M

Clôture Veille

9,24

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

2 471

Actions en circulation

8 991 229

Rendement du Dividende

Ratio Cours sur Bénéfices

18,61

Bénéfice par action (BPA)

0,5

Chiffre d'affairess

Bénéfice net

4,46M

Secteur

Pharmaceutical Preparations

Industrie

Blank Checks

Siège social

Grand Cayman, Cym

Fondé

2023

PowerUp Acquisition Corporation est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker PWUP. Le dernier cours de clôture d'PowerUp Acquisition était de US$9,24. Au cours de la dernière année, les actions de PowerUp Acquisition ont été négociées dans une fourchette de prix de US$ 8,05 à US$ 15,80.

PowerUp Acquisition compte actuellement 8 991 229 actions en circulation. La capitalisation boursière d'PowerUp Acquisition est de US$83,08 million. PowerUp Acquisition a un ratio cours/bénéfice (ratio PE) de 18.61.

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

Highlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of...

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

Humacao, PR and New York, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Aspire Biopharma, Inc. (“Aspire” or the...

PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

New York, NY, June 05, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP...

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

New York, NY, May 20, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP...

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

New York, NY, May 16, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP...

PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination

Tarrytown, NY and New York, NY, Jan. 29, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (“PowerUp”...

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Tarrytown, NY and New York, NY, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Visiox Pharmaceuticals, Inc. (“Visiox” or...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	9.24	9.24	9.24	0	0	CS
4	0	0	9.24	9.24	9.24	0	0	CS
12	-2.26	-19.652173913	11.5	15.8	8.05	2471	11.91641253	CS
26	-2.35	-20.2761000863	11.59	15.8	8.05	1793	11.86480533	CS
52	-1.775	-16.1143894689	11.015	15.8	8.05	6058	11.49207568	CS
156	-0.76	-7.6	10	15.8	8.05	41589	10.42101145	CS
260	-0.76	-7.6	10	15.8	8.05	41589	10.42101145	CS

PWUP - Frequently Asked Questions (FAQ)

What is the current PowerUp Acquisition share price?

The current share price of PowerUp Acquisition is US$ 9,24

How many PowerUp Acquisition shares are in issue?

PowerUp Acquisition has 8 991 229 shares in issue

What is the market cap of PowerUp Acquisition?

The market capitalisation of PowerUp Acquisition is USD 83,08M

What is the 1 year trading range for PowerUp Acquisition share price?

PowerUp Acquisition has traded in the range of US$ 8,05 to US$ 15,80 during the past year

What is the PE ratio of PowerUp Acquisition?

The price to earnings ratio of PowerUp Acquisition is 18,61

What is the reporting currency for PowerUp Acquisition?

PowerUp Acquisition reports financial results in USD

What is the latest annual profit for PowerUp Acquisition?

The latest annual profit of PowerUp Acquisition is USD 4,46M

What is the registered address of PowerUp Acquisition?

The registered address for PowerUp Acquisition is PO BOX 309, UGLAND HOUSE, GRAND CAYMAN, KY1-1104

Which industry sector does PowerUp Acquisition operate in?

PowerUp Acquisition operates in the BLANK CHECKS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
LYTLytus Technologies Holdings PTV Ltd	US$ 0,1455 (133,55%)	358,4M
GTECGreenland Technologies Holding Corporation	US$ 2,17 (65,65%)	35,43M
DRMADermata Therapeutics Inc	US$ 2,1097 (56,27%)	32,99M
CISOCISO Global Inc	US$ 0,6526 (46,52%)	35,06M
SLNOSoleno Therapeutics Inc	US$ 69,88 (42,70%)	2,55M
EQEquillium Inc	US$ 0,50 (-34,04%)	392,98k
AUUDAuddia Inc	US$ 0,22345 (-33,04%)	761,18k
NXUNXU Inc	US$ 0,188 (-29,03%)	2,64M
OSRHOSR Holdings Inc	US$ 2,71 (-28,50%)	638,7k
AREBAmerican Rebel Holdings Inc	US$ 0,0979 (-28,01%)	2,8M
LYTLytus Technologies Holdings PTV Ltd	US$ 0,1455 (133,55%)	358,4M
DMNDamon Inc	US$ 0,0499 (28,28%)	202,04M
OCEAOcean Biomedical Inc	US$ 0,095 (13,50%)	123,58M
GTIGraphjet Technology	US$ 0,134 (24,77%)	80,5M
GTECGreenland Technologies Holding Corporation	US$ 2,17 (65,65%)	35,43M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

PowerUp Acquisition Corporation (PWUP)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de PowerUp Acquisition Corporation

PWUP Dernières nouvelles

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

PWUP - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

PowerUp Acquisition Corporation (PWUP) Cours

PowerUp Acquisition Corporation (PWUP)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de PowerUp Acquisition Corporation

PWUP Dernières nouvelles

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

PWUP - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités